Operating Margin of Aligos Therapeutics, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Aligos Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Aligos Therapeutics, Inc. Operating Margin for the quarter ending 31 Dec 2025 was -4025%, a 63% decline year-over-year.
  • Aligos Therapeutics, Inc. annual Operating Margin for 2025 was -4025%, a 63% decline from 2024.
  • Aligos Therapeutics, Inc. annual Operating Margin for 2024 was -2469%, a 73% decline from 2023.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Aligos Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -4025% -1556% -63% 01 Oct 2025 31 Dec 2025
Q3 2025 -3307% -734% -29% 01 Jul 2025 30 Sep 2025
Q2 2025 -2507% +157% +5.9% 01 Apr 2025 30 Jun 2025
Q1 2025 -2675% -1396% -109% 01 Jan 2025 31 Mar 2025
Q4 2024 -2469% -1045% -73% 01 Oct 2024 31 Dec 2024
Q3 2024 -2572% 01 Jul 2024 30 Sep 2024
Q2 2024 -2663% 01 Apr 2024 30 Jun 2024
Q1 2024 -1279% 01 Jan 2024 31 Mar 2024
Q4 2023 -1423% 01 Oct 2023 31 Dec 2023

Aligos Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2025 -4025% -1556% -63% 01 Jan 2025 31 Dec 2025
2024 -2469% -1045% -73% 01 Jan 2024 31 Dec 2024
2023 -1423% 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.